LILLY DRN
- U.S. News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.…
Read More » - U.S. News
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March…
Read More » - News
Novo Nordisk shares plunge 24% after disappointing trial results; Lilly jumps in premarket
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Shares of…
Read More » - News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty…
Read More » - U.S. News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Patients will be able to access Zepbound single-dose vials at Ro Coutesy: Ro Direct-to-consumer health-care startup Ro on Wednesday said…
Read More » - U.S. News
Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by…
Read More » - News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty…
Read More »